ChemicalBook >> CAS DataBase List >>Vapaliximab

Vapaliximab

Vapaliximab structure

CAS No.: 336801-86-6

Chemical Name:: Vapaliximab

Synonyms: Vapaliximab;Research Grade Vapaliximab;Research Grade Vapaliximab (DHH39202)

CBNumber:: CB28080790

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

TDS File:: TDS

Last updated:2026-04-24 14:58:06

Request For Quotation

Vapaliximab Properties

FDA UNII	M1EGR25LBB

Vapaliximab Chemical Properties,Uses,Production

Uses

Vapaliximab (2D10) is a monoclonal antibody against human VAP-1[1].

References

[1] Salmi M, et al. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans. Blood. 2006 Sep 1;108(5):1555-61. DOI:10.1182/blood-2005-11-4599

Vapaliximab Preparation Products And Raw materials

Raw materials

Preparation Products

Vapaliximab Suppliers

Global( 10)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10305	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7283	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11963	58
Changsha Fuzhen Biotechnology Co.，LTD	15111215862 18229892877	3062105966@qq.com	China	5550	58
Atagenix Laboratories	027-87008169 17762441161	info@atagenix.com	China	9997	58

Supplier	Advantage
ShangHai Biochempartner Co.,Ltd	62
Wuhan Chemstan Biotechnology Co., Ltd.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Changsha Fuzhen Biotechnology Co.，LTD	58
Atagenix Laboratories	58

336801-86-6(Vapaliximab)Related Search:

Urtoxazumab Cotara (9CI) Serclutamab VEGFR2 Kinase Inhibitor I Blosozumab

Sacituzumab Narnatumab Research Grade Tacatuzumab (DHC01501) Efungumab Rilotumumab

1of2

Vapaliximab Research Grade Vapaliximab (DHH39202) Research Grade Vapaliximab 336801-86-6